Search

Your search keyword '"Guan, Zhongzhen"' showing total 6 results
Start Over Author "Guan, Zhongzhen" Journal journal of clinical oncology
6 results on '"Guan, Zhongzhen"'

1. Final analysis of the phase 2 APEC study: Overall survival (OS) data and biomarker subanalyses for first-line FOLFOX or FOLFIRI with cetuximab (cet) once every 2 weeks in patients (pts) with KRAS or RAS (KRAS and NRAS, exons 2-4) wild-type (wt) metastatic colorectal cancer (mCRC).

Author

Cheng, Ann-Lii, primary, Cornelio, Gerardo H., additional, Shen, Lin, additional, Price, Timothy Jay, additional, Yang, Tsai-Sheng, additional, Chung, Ik-Joo, additional, Dai, Guanghai, additional, Lin, Jen-Kou, additional, Sharma, Atul, additional, Yeh, Kun-Huei, additional, Ma, Brigette, additional, Zaatar, Adel, additional, Guan, Zhongzhen, additional, Masood, Nehal, additional, Srimuninnimit, Vichien, additional, Yau, Thomas Cheung, additional, Beier, Frank, additional, Chatterjee, Sudipto, additional, and Lim, Robert S.C., additional

Published
2015
Full Text
View/download PDF

3. Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer

Author

Guan, Zhongzhen, primary, Xu, Binghe, additional, DeSilvio, Michelle L., additional, Shen, Zhenzhou, additional, Arpornwirat, Wichit, additional, Tong, Zhongsheng, additional, Lorvidhaya, Vicharn, additional, Jiang, Zefei, additional, Yang, Junlan, additional, Makhson, Anatoly, additional, Leung, Wai Lim, additional, Russo, Mark W., additional, Newstat, Beth, additional, Wang, Li, additional, Chen, George, additional, Oliva, Cristina, additional, and Gomez, Henry, additional

Published
2013
Full Text
View/download PDF

4. A phase III study of S-1 plus cisplatin versus fluorouracil plus cisplatin in patients with advanced gastric or gastroesophageal junction adenocarcinoma.

Author

Xu, Rui-hua, primary, Sun, Guo-ping, additional, Lu, Hui-shan, additional, Yun Peng, Liu, additional, Xu, Jian-ming, additional, Zhong, Mei-zuo, additional, Zhang, He-long, additional, Yu, Shi-ying, additional, Li, Wei, additional, Hu, Xiao-hua, additional, Wang, Jie Jun, additional, Cheng, Ying, additional, Zhou, Jun-tian, additional, Guo, Zeng-qing, additional, and Guan, Zhongzhen, additional

Published
2013
Full Text
View/download PDF

5. Efficacy and safety of every-2-weeks cetuximab combined with FOLFOX or FOLFIRI as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (mCRC): An Asia-Pacific nonrandomized phase II study (APEC).

Author

Cheng, Ann-Lii, primary, Cornelio, Gerardo H., additional, Shen, Lin, additional, Price, Timothy Jay, additional, Yang, Tsai-Shen, additional, Chung, Ik-Joo, additional, Dai, Guanghai, additional, Lin, Jen-Kou, additional, Sharma, Atul, additional, Yeh, Kun-Huei, additional, Ma, Brigette, additional, Zaatar, Adel, additional, Guan, Zhongzhen, additional, Masood, Nehal, additional, Srimuninnimit, Vichien, additional, Yau, Thomas Cheung, additional, Sarholz, Barbara, additional, and Lim, Robert S.C., additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results